Having determined variability in the expression of proline-hydroxylated HIF-1α in VHL competent cell lines, we used a panel of tissue microarrays to evaluate the expression of total and proline-hydroxylated HIF-1α in hypoxic head and neck, breast, lung and bladder carcinomas (Figure 4). Here, HIF1A is linked to urinary bladder carcinoma.